Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis
Condition(s):Other OsteoporosisLast Updated:October 28, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Other OsteoporosisLast Updated:October 28, 2011Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:January 11, 2011Terminated
Condition(s):PostmenopausalLast Updated:April 17, 2013Completed
Condition(s):OsteoporosisLast Updated:July 30, 2019Completed
Condition(s):Postmenopausal OsteoporosisLast Updated:December 12, 2023Recruiting
Condition(s):Osteogenesis ImperfectaLast Updated:April 22, 2013Completed
Condition(s):Metastatic Prostate CancerLast Updated:May 26, 2016Terminated
Condition(s):Osteoporosis, PostmenopausalLast Updated:October 30, 2007Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:June 6, 2018Completed
Condition(s):OsteoporosisLast Updated:July 28, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.